MASNERI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 895
EU - Europa 475
AS - Asia 157
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.532
Nazione #
US - Stati Uniti d'America 892
IT - Italia 118
CN - Cina 101
PL - Polonia 100
UA - Ucraina 87
DE - Germania 54
HK - Hong Kong 42
FI - Finlandia 36
GB - Regno Unito 23
IE - Irlanda 17
FR - Francia 10
SE - Svezia 10
ES - Italia 9
VN - Vietnam 8
SG - Singapore 5
RU - Federazione Russa 4
CA - Canada 3
RO - Romania 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
DK - Danimarca 1
EU - Europa 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 1.532
Città #
Fairfield 132
Warsaw 100
Ashburn 91
Houston 86
Jacksonville 72
Woodbridge 71
Seattle 55
Ann Arbor 53
Chandler 49
Hong Kong 42
New York 40
Wilmington 40
Cambridge 39
Beijing 36
Princeton 36
Brescia 34
Helsinki 31
Dublin 17
Dearborn 14
Nanjing 12
Milan 11
Shanghai 10
Des Moines 9
San Diego 9
Dong Ket 8
Bergamo 7
Changsha 6
Tianjin 5
Jinan 4
San Francisco 4
Santiago De Compostela 4
Guangzhou 3
Hebei 3
Jiaxing 3
Lancaster 3
London 3
Mariano Comense 3
Nanchang 3
Napoli 3
Neustadt 3
Redwood City 3
Rome 3
Sevilla 3
Shenyang 3
Brooklyn 2
Brussels 2
Haikou 2
Lanzhou 2
New Bedfont 2
North York 2
Qingdao 2
Segrate 2
Todi 2
Whitley Bay 2
Baotou 1
Boardman 1
Bratislava 1
Castiglione Delle Stiviere 1
Dallas 1
Darfo 1
Falkenstein 1
Fremont 1
Fuzhou 1
Hangzhou 1
Islington 1
Kunming 1
Lincoln 1
Mandurah 1
Melbourne 1
Norwalk 1
Nottingham 1
Omsk 1
Parla 1
Passirano 1
Phoenix 1
Redmond 1
Singapore 1
St Petersburg 1
Taizhou 1
Toronto 1
Toscolano-Maderno 1
Verolanuova 1
Verona 1
Weimar 1
Totale 1.216
Nome #
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 144
CRI DU CHAT INDUCED PLURIPOTENT STEM CELLS: NEW FRONTIERS IN DISEASE UNDERSTANDING 135
CRI DU CHAT INDUCED PLURIPOTENT STEM CELLS: NEW FRONTIERS IN DISEASE UNDERSTANDING 130
Generation of induced pluripotent stem cells (iPSCs) from patient with Cri du Chat Syndrome 120
Correlation of bone marrow abnormalities, peripheral lymphocyte subsets and clinical features in uncomplicated common variable immunodeficiency (CVID) patients 110
Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment 105
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 77
ALTERED B AND T LYMPHOCYTE HOMEOSTASIS IN THE BONE MARROW AND THE PERIPHERY CORRELATES WITH CLINICAL FINDINGS IN COMMON VARIABLE IMMUNODEFICIENCY (CVID) 75
Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene 75
Biomarkers and precision therapy for primary immunodeficiencies: an in vitro study based on induced pluripotent stem cells (iPSCs) from patients 70
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B 70
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 69
CASE REPORT: IDENTIFICATION OF A PATIENT WITH FAMILIAR MUTATIONS AFFECTING BOTH WASP AND FOXP3 GENES 65
WASP-WIP DEFICIENCIES: NEW INSIGHTS IN WASP-WIP INTERACTION 63
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 53
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene 52
Generation of induced pluripotent stem cell (iPSC) lines from a Joubert syndrome patient with compound heterozygous mutations in C5orf42 gene 49
PAX1 is essential for development and function of the human thymus 43
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 35
Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene 19
Successful CAR-T cell therapy in a refractory MCL patient with bacterial, fungal and COVID-19 infection: a case report 15
Totale 1.574
Categoria #
all - tutte 7.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 0 20 13
2019/2020481 26 6 7 43 48 67 52 52 43 80 28 29
2020/2021406 17 47 13 45 31 69 12 40 31 46 26 29
2021/2022191 14 17 8 16 0 11 11 12 9 31 25 37
2022/2023150 19 4 9 5 12 39 0 15 27 2 8 10
2023/2024211 16 1 27 15 26 53 8 12 46 6 1 0
Totale 1.574